Smith's current contract — which expires after the 2025 season — has an average per-year value of $25 million, which ranks 19th in the NFL. His cap hit is $44.5 million next season, the largest of his ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Should the Seahawks extend Geno Smith? How can the Bears best support Caleb Williams? Kevin Patra identifies one key ...